Outcome and safety of single-dose docetaxel–augmented targeted radionuclide therapy using [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in treatment-refractory mCRPC: preliminary evidence from a pilot experience. - Ebert, Niklas; Rosar, Florian; Burgard, Caroline; Bartholomä, Mark; Maus, Stephan; Hein, Connor; Blickle, Arne; Ezziddin, Samer; Khreish, Fadi (EJNMMI Research, 2026)